Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference
Moderna's stock is undervalued, so I maintain a positive outlook with a $97 price target for next year. 3Q24
Moderna's stock is undervalued, so I maintain a positive outlook with a $97 price target for next year. 3Q24
